The Asia-Pacific perspective:
Redefining obesity and its treatment

This document has been coordinated by the International Diabetes Institute,
a World Health Organization Collaborating Centre for the Epidemiology
of Diabetes Mellitus and Health Promotion for Noncommunicable Diseases,
with an education grant from Knoll Pharmaceuticals.

Co-sponsored jointly by the Regional Office for the Western Pacific (WPRO),
World Health Organization, the International Association for the Study of Obesity
and the International Obesity Task Force.